General Information of DTT (ID: TTUW6OP)

DTT Name Complement factor H (CFH) DTT Info
Gene Name CFH

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Trumenba DMDHCK9 Meningitis 1D01 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
GT103 DMX2J57 Non-small-cell lung cancer 2C25.Y Phase 1 [2]
TT-30 DMLDSX8 Autoimmune diabetes 5A10 Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.
2 Clinical pipeline report, company report or official report of Grid Therapeutics.
3 The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment. Blood. 2012 Jun 28;119(26):6307-16.